Brief: Eve Health Says Sale Of Investment In Omni Innovation
Dec 20 (Reuters) - Eve Health EVE.AX :
* SALE OF INVESTMENT IN OMNI INNOVATION
* COMPLETED SALE OF 38% INTEREST IN OMNI INNOVATION TO
MYOPHARM
Source text for Eikon: ID:nASXQJFLd
Further company coverage: EVE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eve Health
See all newsBrief: Eve Health Appoints Ben Rohr As Chief Executive Officer
Australia's EVE Health slips on discounted placement
Brief: Eve Health Group Seeks Trading Halt For Capital Raising Consideration And Planning
Brief: Eve Health Signs Telehealth Services Agreement With Hubmed
Brief: Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share